BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7051368)

  • 1. Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
    Cassone A; Bistoni F; Cenci E; Pesce CD; Tissi L; Marconi P
    Sabouraudia; 1982 Jun; 20(2):115-25. PubMed ID: 7051368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
    Delfina Pesce C; Boccanera M; Marconi P; Bistoni F; Cenci E; Tissi L; Cassone A
    Ann Ist Super Sanita; 1982; 18(3):509-12. PubMed ID: 7187836
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of wall glucans from yeast, hyphal and germ-tube forming cells of Candida albicans.
    Gopal PK; Shepherd MG; Sullivan PA
    J Gen Microbiol; 1984 Dec; 130(12):3295-301. PubMed ID: 6394718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
    Marconi P; Bistoni F
    Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F
    Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions.
    Jawhara S; Habib K; Maggiotto F; Pignede G; Vandekerckove P; Maes E; Dubuquoy L; Fontaine T; Guerardel Y; Poulain D
    PLoS One; 2012; 7(7):e40648. PubMed ID: 22848391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Friend leukemia cell-induced tumours by cellular preparations of Candida albicans.
    Cassone A; Scaringi L; Pesce CD; Titti F; Bistoni F; Marconi P; Rossi GB
    Microbiologica; 1983 Jul; 6(3):207-20. PubMed ID: 6355774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    Immunology; 1988 Oct; 65(2):181-5. PubMed ID: 2847978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species.
    Kanbe T; Utsunomiya K; Ishiguro A
    Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice.
    Miura NN; Miura T; Ohno N; Adachi Y; Watanabe M; Tamura H; Tanaka S; Yadomae T
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):123-9. PubMed ID: 9685001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.
    Marconi P; Scaringi L; Tissi L; Puccetti P; Cassone A
    Int J Immunopharmacol; 1984; 6(3):217-22. PubMed ID: 6378809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans.
    Schaffer T; Müller S; Flogerzi B; Seibold-Schmid B; Schoepfer AM; Seibold F
    Inflamm Bowel Dis; 2007 Nov; 13(11):1339-46. PubMed ID: 17636567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition of the cell walls of several yeast species.
    Nguyen TH; Fleet GH; Rogers PL
    Appl Microbiol Biotechnol; 1998 Aug; 50(2):206-12. PubMed ID: 9763691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent association of beta-1,3-glucan with beta-1,6-glucosylated mannoproteins in cell walls of Candida albicans.
    Kapteyn JC; Montijn RC; Dijkgraaf GJ; Van den Ende H; Klis FM
    J Bacteriol; 1995 Jul; 177(13):3788-92. PubMed ID: 7541400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (1-->3)-beta-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor.
    Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Hara K
    J Clin Lab Anal; 1995; 9(5):334-9. PubMed ID: 8531015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions.
    Scaringi L; Marconi P; Boccanera M; Tissi L; Bistoni F; Cassone A
    J Gen Microbiol; 1988 May; 134(5):1265-74. PubMed ID: 3058863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of immunoadjuvant activity of an orally administered glucan extracted from Candida albicans.
    Nicoletti A; Nicoletti G; Ferraro G; Palmieri G; Mattaboni P; Germogli R
    Arzneimittelforschung; 1992 Oct; 42(10):1246-50. PubMed ID: 1472146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of lymphokine-activated killer cell activity by cell wall components of Candida albicans.
    Scaringi L; Rosati E; Cornacchione P; Rossi R; Marconi P
    Cell Immunol; 1992 Feb; 139(2):438-54. PubMed ID: 1733513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.